CORI Corium International Inc.

11.67
+0.72  (7%)
Previous Close 10.95
Open 10.98
Price To book 15.36
Market Cap 417116784
Shares 35,742,655
Volume 165,019
Short Ratio 15.37
Av. Daily Volume 171,151

SEC filingsSee all SEC filings

  1. 8-K - Current report 171208192
  2. CT ORDER - Confidential treatment order 171096653
  3. 10-Q - Quarterly report [Sections 13 or 15(d)] 171025056
  4. 8-K - Current report 171005397
  5. 8-K - Current report 17966143

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 3 top-line data released January 3, 2017 - poor data. NDA resubmitted by partner Agile Therapeutics with PDUFA date of December 26, 2017
Twirla
Contraceptive patch
Pilot bioequivalence data due released May 11, 2017. Pivotal trial commenced fall of 2017 with preliminary data due 1H 2018.
Corplex Donepezil
Alzheimer's disease
Phase 2a data released July 2015
MicroCor PTH
Osteoporosis
Additional Phase 3 required following rejection of NDA. Trial is ongoing by partner Agile
AG200-15
Contraceptive